Lengyel, C.G.; Hussain, S.; Seeber, A.; Jamil Nidhamalddin, S.; Trapani, D.; Habeeb, B.S.; Elfaham, E.; Mazher, S.A.; Seid, F.; Khan, S.Z.;
et al. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target? Life 2022, 12, 81.
https://doi.org/10.3390/life12010081
AMA Style
Lengyel CG, Hussain S, Seeber A, Jamil Nidhamalddin S, Trapani D, Habeeb BS, Elfaham E, Mazher SA, Seid F, Khan SZ,
et al. FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target? Life. 2022; 12(1):81.
https://doi.org/10.3390/life12010081
Chicago/Turabian Style
Lengyel, Csongor G., Sadaqat Hussain, Andreas Seeber, Sara Jamil Nidhamalddin, Dario Trapani, Baker S. Habeeb, Essam Elfaham, Syed Ayub Mazher, Fahmi Seid, Shah Z. Khan,
and et al. 2022. "FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?" Life 12, no. 1: 81.
https://doi.org/10.3390/life12010081
APA Style
Lengyel, C. G., Hussain, S., Seeber, A., Jamil Nidhamalddin, S., Trapani, D., Habeeb, B. S., Elfaham, E., Mazher, S. A., Seid, F., Khan, S. Z., El Bairi, K., Odhiambo, A., Altuna, S. C., & Petrillo, A.
(2022). FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target? Life, 12(1), 81.
https://doi.org/10.3390/life12010081